Mode
Text Size
Log in / Sign up

Meta-analysis finds respiratory muscle training improves some lung function measures in multiple sclerosis

Meta-analysis finds respiratory muscle training improves some lung function measures in multiple scl…
Photo by julien Tromeur / Unsplash
Key Takeaway
Consider respiratory muscle training for modest lung function gains in MS, but evidence is limited.

This publication is a systematic review and meta-analysis that evaluates the effects of respiratory muscle training on respiratory function in patients with multiple sclerosis. It synthesizes data from studies involving 249 patients, focusing on outcomes such as maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), forced vital capacity (FVC), forced expiratory volume in one second (FEV), and the FEV/FVC ratio. The comparator and follow-up duration are not reported, and the analysis does not specify primary or secondary outcomes beyond these measures.

The meta-analysis found significant improvements in several respiratory parameters. For maximal expiratory pressure, the standardized mean difference (SMD) was 0.42 (95% CI [0.09-0.76], p = 0.01). Maximal inspiratory pressure showed an SMD of 0.32 (95% CI [0.02-0.63], p = 0.04). Forced expiratory volume in one second had an SMD of 0.41 (95% CI [0.08-0.74], p = 0.01), and the FEV/FVC ratio had an SMD of 0.52 (95% CI [0.15-0.89], p = 0.005). However, forced vital capacity did not show a significant benefit, with an SMD of 0.28 (p = 0.06).

Limitations include a small total sample size of 249 patients, which may reduce the generalizability and precision of the findings. Adverse events, serious adverse events, discontinuations, and tolerability are not reported, limiting safety assessments. The authors do not provide details on funding or conflicts of interest, and the practice relevance is unspecified, suggesting cautious interpretation.

In practice, these results indicate that respiratory muscle training may modestly improve certain lung function measures in multiple sclerosis, but the evidence is based on pooled data with methodological gaps. Clinicians should consider the unreported safety profile and the lack of long-term follow-up when applying these findings. Further research is needed to confirm benefits and assess clinical outcomes beyond respiratory parameters.

Study Details

Study typeMeta analysis
Sample sizen = 249
EvidenceLevel 1
PublishedJan 2026
View Original Abstract ↓
INTRODUCTION: Multiple sclerosis (MS) has a high incidence and can occur at all ages, and respiratory dysfunction is a leading cause of death among the complications of MS. Respiratory muscle training (RMT) is often used to help MS patients improve their respiratory function, but the specific impact of RMT has not been clearly elucidated. The present meta-analysis aims to evaluate the impact of RMT on MS patients. METHODS: We looked up PubMed, Cochrane Library, Embase, Web of Science, and PEDro with the query "respiratory muscle training" AND "multiple sclerosis". The cutoff was January 6, 2026. After screening, eligible randomized controlled clinical trials were analyzed to calculate the standardized mean differences (SMDs) and 95% confidence intervals (CI) of the following metrics regarding RMT intervention: maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), forced vital capacity (FVC), forced expiratory volume in one second (FEV), and the ratio of forced expiratory volume in one second to forced vital capacity (FEV/FVC). RESULTS: A total of 370 articles were retrieved, and eight remained after rigorous screening. The eight trials included a total of 249 patients. Patients undergoing RMT exhibited significant improvements in MEP (SMD = 0.42, 95% CI [0.09-0.76],  = 0.01, I = 24%), MIP (SMD = 0.32, 95% CI [0.02-0.63],  = 0.04, I = 17%), FEV (SMD = 0.41, 95% CI [0.08-0.74],  = 0.01, I =9%), and FEV/FVC (SMD = 0.52, 95% CI [0.15-0.89],  = 0.005, I =0%), but FVC did not benefit from RMT (SMD = 0.28,  = 0.06). CONCLUSIONS: Respiratory muscle training can improve respiratory muscle strength and the lung function in MS patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.